| Julie W Bates, CNM | |
|
210 Sunnyview Ln, Suite 101, Kalispell, MT 59901-3135 | |
| (406) 751-8009 | |
| (406) 257-6463 |
| Full Name | Julie W Bates |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 210 Sunnyview Ln, Kalispell, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558316026 | NPI | - | NPPES |
| 1558316026 | Other | MT | BCBS |
| 1558316026 | Medicaid | MT | |
| 6215 | Other | ACNM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | RN25420 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Julie W Bates, CNM 210 Sunnyview Ln, Suite 101, Kalispell, MT 59901-3135 Ph: (406) 751-8009 | Julie W Bates, CNM 210 Sunnyview Ln, Suite 101, Kalispell, MT 59901-3135 Ph: (406) 751-8009 |
News Archive
Eli Lilly and Company and SGX Pharmaceuticals, Inc. today announced that the companies have signed a definitive merger agreement providing for the acquisition of SGX in an all-cash transaction. SGX, based in San Diego, California, is a biotechnology company focused on drug discovery and development in the area of oncology.
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced it has shipped its first commercial order of DAVANAT® to PROCAPS S.A., a large, international pharmaceutical company based in Barranquilla, Colombia. The $200,000 shipment of DAVANAT® will be used by PROCAPS to qualify its vial filling process.
Harvard School of Public Health (HSPH) researchers and colleagues from Research Institute for a Tobacco Free Society have found that a reduction in secondhand smoking in American homes was associated with fewer cases of otitis media, the scientific name for middle ear infection. The study appears on January 26, 2011, as an online first article on the website of the journal Tobacco Control.
The Institute for Systems Biology (ISB) of Seattle, WA, is collaborating with the Gladstone Institute of Neurological Disease (GIND) and its Taube-Koret Center for Huntington's Disease Research to use whole-genome sequencing to identify genes and novel drug targets related to the onset and progression of Huntington's disease (HD). The research team, led by GIND associate director and senior investigator Steven Finkbeiner, MD, PhD, will also use induced pluripotent stem (iPS) cells from patients with HD to screen for drugs that might delay, prevent, or even reverse this devastating condition.
› Verified 5 days ago
Christie Weseman, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 210 Sunnyview Ln Ste 101, Kalispell, MT 59901 Phone: 406-751-8009 Fax: 406-257-6463 | |
Misha Russ, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 770 W Reserve Dr Ste 3, Kalispell, MT 59901 Phone: 406-300-4511 | |
Jeanne M Baker, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 35 5th Ave W, Kalispell, MT 59901 Phone: 406-871-8888 | |
Honey Michelle Newton, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 770 W Reserve Dr Ste 3, Kalispell, MT 59901 Phone: 406-300-4511 Fax: 406-258-0497 | |
Amber Lavin, DNP, CNM, WHNP Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 210 Sunnyview Ln Ste 101, Kalispell, MT 59901 Phone: 406-751-8009 Fax: 406-257-6463 | |
Pamela A Parsons, APRN Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 195 Commons Loop, Suite D, Kalispell, MT 59901 Phone: 406-752-8180 Fax: 406-752-1056 |